Analyst Consensus ?
ConsensusBuy53 ratings
Bullish4584.9%
Neutral713.2%
Bearish11.9%
The TJX Companies, Inc. · TJX · FY2027 Q2 · Calendar Q3 2026
TJX raises outlook as value demand remains firm
The quarter supports a constructive operating thesis: demand for TJX’s value proposition remains resilient, while store expansion, merchandise availability, and marketing provide avenues for continued growth. The thesis is tempered by Marmaxx execution issues and cost-related uncertainty.
Reported Before market openNYSEConsumer Cyclical
$140.56B market cap
100quality score
Earnings scorecard
Reported versus consensus
Reported EPS
$1.22
Consensus $1.19
EPS surprise
+2.5%
Reported versus consensus
Reported revenue
$15.18B
Consensus $15.16B
Revenue surprise
+0.1%
Reported versus consensus
Market reaction
prior-close to event-session close
Stock move
-4.2%
Event window
SPY move
+0.2%
Same window
Abnormal move
-4.4%
Stock minus SPY
Volume
2.5×
Versus trailing sessions
Subsequent drift
-12.4%
Up to 20 sessions
TJXSPY benchmark
Ask FN2 about TJX FY2027 Q2
Transcript, numbers and history already loaded
Why did TJX fall 4.2% after beating EPS estimates in FY2027 Q2?What changed in TJX's guidance and outlook in FY2027 Q2?Give me the bull and bear case for TJX after FY2027 Q2 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
The latest analysis shows stronger-than-planned comparable sales, improved performance signals at Marmaxx, raised full-year profitability and earnings guidance, and a higher store-count ambition. Management also emphasized faster expansion and more digital marketing while acknowledging execution and cost risks.
Guidance delta
Management raised its full-year pretax margin and earnings outlook.
Key takeaways
- Comparable sales exceeded the company’s plan, with three of four divisions performing strongly.
- Marmaxx lagged, but management said early signs of improvement were emerging.
- Management attributed the broader performance to value demand, merchandise availability, and diversified sourcing.
- Store expansion and digital marketing remain central to the growth plan.
- The main counterweights are Marmaxx execution, cost pressure, and tariff-refund uncertainty.
Management priorities
- Improve merchandise planning and allocation at Marmaxx.
- Accelerate domestic and international store expansion.
- Invest in digital and social-media marketing.
- Maintain merchandise availability through diversified vendor relationships.
- Prepare holiday merchandising and marketing campaigns.
Follow TJX with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$128.41Current
$67Low
$137.48Average
$198High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 21, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Jefferies | Hold | Buy | Downgrade | Aug 26, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Aug 20, 2026 |
| UBS | Buy | Buy | Maintain | Aug 20, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Aug 20, 2026 |
| Gordon Haskett | Accumulate | Buy | Maintain | Aug 20, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Aug 20, 2026 |
| Citigroup | Neutral | Buy | Downgrade | Aug 20, 2026 |
| BTIG | Buy | Buy | Maintain | Aug 20, 2026 |
| Barclays | Overweight | Overweight | Maintain | Aug 20, 2026 |
| Truist Securities | Buy | Buy | Maintain | May 21, 2026 |
| Telsey Advisory Group | Outperform | Outperform | Maintain | May 21, 2026 |
| Baird | Outperform | Outperform | Maintain | May 21, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | May 18, 2026 |
| TD Cowen | Buy | Buy | Maintain | Nov 20, 2025 |
| Goldman Sachs | Buy | Buy | Maintain | Nov 20, 2025 |
| Bernstein | Outperform | Outperform | Maintain | Nov 20, 2025 |
| B of A Securities | Buy | Buy | Maintain | Nov 20, 2025 |
| Loop Capital | Buy | Buy | Maintain | May 22, 2025 |
| TD Securities | Buy | Buy | Maintain | May 20, 2025 |
| BMO Capital | Outperform | Outperform | Maintain | Feb 27, 2025 |
| Guggenheim | Buy | Buy | Maintain | Dec 5, 2024 |
| Deutsche Bank | Buy | Buy | Maintain | Nov 21, 2024 |
| Redburn Atlantic | Neutral | Buy | Downgrade | Feb 5, 2024 |
| Argus Research | Buy | Buy | Maintain | Aug 21, 2023 |
| Cleveland Research | Buy | Neutral | Upgrade | Aug 9, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Feb 23, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Nov 17, 2022 |
| RBC Capital | Outperform | Outperform | Maintain | Feb 25, 2021 |
| Nomura Instinet | Buy | Buy | Maintain | May 22, 2020 |
| Nomura | Buy | Buy | Maintain | May 22, 2020 |
| CFRA | Strong Buy | Strong Buy | Maintain | May 21, 2020 |
| Atlantic Equities | Overweight | Neutral | Upgrade | Apr 29, 2020 |
| Cowen& Co. | Outperform | Outperform | Maintain | Dec 8, 2019 |
| DA Davidson | Buy | Buy | Maintain | Nov 20, 2019 |
| Citi | Buy | Buy | Maintain | Nov 20, 2019 |
| Wedbush | Neutral | Neutral | Maintain | Nov 15, 2019 |
| MKM Partners | Buy | Buy | Maintain | Feb 28, 2019 |
| Argus | Buy | Hold | Upgrade | Nov 29, 2018 |
| Bank of America | Buy | Buy | Maintain | Aug 22, 2018 |
| Buckingham Research | Buy | Buy | Maintain | Aug 20, 2018 |
| Buckingham | Buy | Buy | Maintain | Aug 20, 2018 |
| Susquehanna | Outperform | Positive | Maintain | Feb 10, 2017 |
| Wolfe Research | Outperform | Outperform | Maintain | Feb 2, 2016 |
| BB&T Capital | Buy | Buy | Maintain | Dec 17, 2015 |
| Cantor Fitzgerald | Hold | Hold | Maintain | Nov 18, 2015 |
| Sterne Agee | Neutral | Neutral | Maintain | Nov 19, 2014 |
| Canaccord Genuity | Sell | Hold | Downgrade | Nov 14, 2014 |
| Northcoast Research | Buy | Neutral | Upgrade | Jul 24, 2014 |
| SunTrust Robinson Humphrey | Buy | Neutral | Upgrade | May 21, 2014 |
| Stifel Nicolaus | Buy | Buy | Maintain | Oct 22, 2013 |
| Stifel | Buy | Buy | Maintain | Oct 22, 2013 |
| Miller Tabak | Buy | Buy | Maintain | Feb 28, 2013 |
| ISI Group | Buy | Buy | Maintain | Aug 14, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $128.41. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Guggenheim | Analyst unavailable | $152 | $135.14 | +18.4% | Aug 31, 2026 |
| Jefferies | Corey Tarlowe | $145 | $139.48 | +12.9% | Aug 26, 2026 |
| Bernstein | Aneesha Sherman | $175 | $140.46 | +36.3% | Aug 25, 2026 |
| Evercore ISI | Michael Binetti | $173 | $144.5 | +34.7% | Aug 20, 2026 |
| Gordon Haskett Capital Corporation | Analyst unavailable | $155 | $144.5 | +20.7% | Aug 20, 2026 |
| Morgan Stanley | Analyst unavailable | $178 | $144.5 | +38.6% | Aug 20, 2026 |
| UBS | Analyst unavailable | $198 | $144.5 | +54.2% | Aug 20, 2026 |
| Barclays | Analyst unavailable | $188 | $144.5 | +46.4% | Aug 20, 2026 |
| Morgan Stanley | Alex Straton | $181 | $157.55 | +41.0% | Aug 5, 2026 |
| Telsey Advisory | Dana Telsey | $185 | $156.72 | +44.1% | May 21, 2026 |
| Truist Financial | Analyst unavailable | $190 | $156.82 | +48.0% | May 21, 2026 |
| UBS | Analyst unavailable | $197 | $157.11 | +53.4% | May 21, 2026 |
| Evercore ISI | Michael Binetti | $175 | $158.12 | +36.3% | May 21, 2026 |
| BTIG | Bob Drbul | $190 | $159.21 | +48.0% | May 21, 2026 |
| Robert W. Baird | Analyst unavailable | $175 | $159.21 | +36.3% | May 21, 2026 |
| Wells Fargo | Analyst unavailable | $160 | $159.21 | +24.6% | May 21, 2026 |
| Barclays | Adrienne Yih | $190 | $159.21 | +48.0% | May 21, 2026 |
| Truist Financial | Analyst unavailable | $175 | $147.43 | +36.3% | May 18, 2026 |
| BTIG | Bob Drbul | $185 | $155.82 | +44.1% | Feb 26, 2026 |
| Deutsche Bank | Analyst unavailable | $184 | $157.4 | +43.3% | Jan 8, 2026 |
| UBS | Analyst unavailable | $193 | $154.04 | +50.3% | Jan 8, 2026 |
| Bernstein | Aneesha Sherman | $170 | $153.57 | +32.4% | Jan 6, 2026 |
| Robert W. Baird | Analyst unavailable | $168 | $155.09 | +30.8% | Dec 17, 2025 |
| Wells Fargo | Analyst unavailable | $150 | $156.78 | +16.8% | Dec 16, 2025 |
| Guggenheim | Simeon Siegel | $175 | $153.7 | +36.3% | Dec 9, 2025 |
| UBS | Jay Sole | $181 | $150.71 | +41.0% | Dec 4, 2025 |
| Robert W. Baird | Analyst unavailable | $165 | $150.06 | +28.5% | Dec 4, 2025 |
| Barclays | Adrienne Yih | $172 | $150.06 | +33.9% | Dec 4, 2025 |
| Robert W. Baird | Mark Altschwager | $160 | $145.44 | +24.6% | Nov 20, 2025 |
| Morgan Stanley | Alex Straton | $162 | $145.81 | +26.2% | Nov 20, 2025 |
| Goldman Sachs | Brooke Roach | $170 | $145.81 | +32.4% | Nov 20, 2025 |
| Wells Fargo | Ike Boruchow | $145 | $145.81 | +12.9% | Nov 20, 2025 |
| Barclays | Analyst unavailable | $168 | $148.45 | +30.8% | Nov 20, 2025 |
| Bernstein | Aneesha Sherman | $155 | $145.81 | +20.7% | Nov 20, 2025 |
| Evercore ISI | Analyst unavailable | $165 | $145.81 | +28.5% | Nov 19, 2025 |
| Jefferies | Corey Tarlowe | $170 | $146.72 | +32.4% | Nov 11, 2025 |
| UBS | Jay Sole | $172 | $140.78 | +33.9% | Nov 4, 2025 |
| Wells Fargo | Analyst unavailable | $140 | $141.91 | +9.0% | Oct 27, 2025 |
| BTIG | Analyst unavailable | $165 | $144.1 | +28.5% | Oct 14, 2025 |
| Loop Capital Markets | Laura Champine | $150 | $129.58 | +16.8% | May 22, 2025 |
| Morgan Stanley | Alex Straton | $140 | $129.58 | +9.0% | May 22, 2025 |
| UBS | Jay Sole | $164 | $129.58 | +27.7% | May 22, 2025 |
| TD Securities | John Kernan | $142 | $134.93 | +10.6% | May 21, 2025 |
| UBS | Jay Sole | $151 | $120.06 | +17.6% | Jan 10, 2025 |
| Robert W. Baird | Mark Altschwager | $128 | $120.23 | -0.3% | Aug 22, 2024 |
| Citigroup | Paul Lejuez | $128 | $120.23 | -0.3% | Aug 22, 2024 |
| Wells Fargo | Ike Boruchow | $115 | $120.23 | -10.4% | Aug 22, 2024 |
| Barclays | Adrienne Yih | $136 | $120.23 | +5.9% | Aug 22, 2024 |
| Telsey Advisory | Dana Telsey | $128 | $111.48 | -0.3% | Aug 16, 2024 |
| Robert W. Baird | Mark Altschwager | $113 | $101.12 | -12.0% | May 23, 2024 |
| BMO Capital | Simeon Siegel | $110 | $99.52 | -14.3% | May 23, 2024 |
| Wells Fargo | Ike Boruchow | $100 | $101.12 | -22.1% | May 23, 2024 |
| CFRA | Aaron Siegel | $100 | $101.12 | -22.1% | May 22, 2024 |
| Morgan Stanley | Alex Straton | $113 | $95.11 | -12.0% | May 6, 2024 |
| UBS | Jay Sole | $132 | $93.82 | +2.8% | May 2, 2024 |
| Goldman Sachs | Brooke Roach | $110 | $95.28 | -14.3% | Apr 25, 2024 |
| J.P. Morgan | Analyst unavailable | $95 | $80.52 | -26.0% | Feb 6, 2023 |
| Wells Fargo | Analyst unavailable | $78 | $80.05 | -39.3% | Dec 1, 2022 |
| Telsey Advisory | Telsey Advisory Telsey Advisory | $95 | $78.16 | -26.0% | Nov 21, 2022 |
| Barclays | Analyst unavailable | $94 | $77.99 | -26.8% | Nov 18, 2022 |
| Cowen & Co. | Analyst unavailable | $84 | $77.16 | -34.6% | Nov 17, 2022 |
| Goldman Sachs | Analyst unavailable | $80 | $77.02 | -37.7% | Nov 17, 2022 |
| Deutsche Bank | Analyst unavailable | $85 | $77.08 | -33.8% | Nov 17, 2022 |
| Wells Fargo | Analyst unavailable | $74 | $75.85 | -42.4% | Nov 17, 2022 |
| Morgan Stanley | Analyst unavailable | $83 | $77.1 | -35.4% | Nov 17, 2022 |
| Credit Suisse | Analyst unavailable | $85 | $79.02 | -33.8% | Nov 17, 2022 |
| Citigroup | Analyst unavailable | $86 | $74 | -33.0% | Nov 11, 2022 |
| Loop Capital Markets | Laura Champine | $65 | $68.01 | -49.4% | Aug 19, 2022 |
| Goldman Sachs | Brooke Roach | $70 | $62.65 | -45.5% | Aug 2, 2022 |
| UBS | Jay Sole | $71 | $62.03 | -44.7% | Jun 6, 2022 |
| Gordon Haskett Capital Corporation | Chuck Grom | $67 | $57.87 | -47.8% | May 22, 2022 |
| Morgan Stanley | Kimberly Greenberger | $80 | $60.19 | -37.7% | May 19, 2022 |
| J.P. Morgan | Matthew Boss | $76 | $56.36 | -40.8% | May 16, 2022 |
| Barclays | Adrienne Yih | $85 | $65.2 | -33.8% | Apr 19, 2022 |
| Wells Fargo | Ike Boruchow | $60 | $61.56 | -53.3% | Apr 9, 2022 |
| Truist Financial | Beth Reed | $82 | $64.69 | -36.1% | Feb 24, 2022 |
| Deutsche Bank | Gabriella Carbone | $79 | $64.69 | -38.5% | Feb 24, 2022 |
| BMO Capital | Simeon Siegel | $75 | $62.5 | -41.6% | Feb 23, 2022 |
| J.P. Morgan | Matthew Boss | $81 | $62.5 | -36.9% | Feb 23, 2022 |
| Guggenheim | Robert Drbul | $80 | $62.5 | -37.7% | Feb 23, 2022 |
| Jefferies | Corey Tarlowe | $90 | $62.5 | -29.9% | Feb 23, 2022 |
| Robert W. Baird | Mark Altschwager | $78 | $62.5 | -39.3% | Feb 23, 2022 |
| Deutsche Bank | Gabriella Carbone | $83 | $67.1 | -35.4% | Feb 16, 2022 |
| Argus Research | Chris Graja | $88 | $69.1 | -31.5% | Nov 26, 2021 |
| Loop Capital Markets | Laura Champine | $70 | $72.83 | -45.5% | Nov 18, 2021 |
| MKM Partners | Roxanne Meyer | $87 | $73.49 | -32.2% | Aug 20, 2021 |
Track every rating change on TJX the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationThe TJX Companies, Inc., alongside its various associated businesses, functions as a major discount retailer focusing on clothing and household decor. Its operations are organized into four primary divisions: Marmaxx, HomeGoods, TJX Canada, and TJX International. The enterprise markets an extensive selection of goods, including clothing for all family members (such as shoes and complementary items); a broad array of home furnishings and accessories (ranging from essential household goods, furniture, floor coverings, and lighting fixtures to gift items, soft textiles, decorative pieces, dining wares, and kitchen utensils), alongside growing departments for pet supplies, children's products, and gourmet foodstuffs.…
Historical context
All TJX earningsConsumer Cyclical peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| LEN-B Lennar Corporation | FY2026 Q3 · Calendar Q3 2026 | — | — | Lennar: Efficiency Gains Offset Housing-Market Pressures |
| LEN Lennar Corporation | FY2026 Q3 · Calendar Q3 2026 | — | -4.1% | Lennar Holds Volume Guidance as Margins Improve Despite Housing Headwinds |
| TCOM Trip.com Group Limited | FY2026 Q2 · Calendar Q3 2026 | +22.3% | +3.0% | Trip.com pairs international growth with heavier AI investment |
| CASY Casey's General Stores, Inc. | FY2027 Q1 · Calendar Q3 2026 | +8.7% | -14.2% | Casey's Q1: Prepared Food Drives Growth as Fuel Margins Stay Volatile |
| LULU Lululemon Athletica Inc. | FY2026 Q2 · Calendar Q3 2026 | +63.1% | -17.4% | Lululemon lowers FY2026 outlook as North America weakens |
| FIVE Five Below, Inc. | FY2027 Q2 · Calendar Q3 2026 | +20.0% | -1.3% | Five Below raises outlook as its retail flywheel gains momentum |
Latest beats and misses
Who reports nextBeat on EPS
- FPSFY2026 Q4 · September 15, 2026+4.3% EPS+9.5% move
- TCOMFY2026 Q2 · September 15, 2026+22.3% EPS+3.0% move
- KRFY2026 Q2 · September 11, 2026+2.8% EPS+2.7% move
- ADBEFY2026 Q3 · September 10, 2026+0.8% EPS+1.4% move
- ORCLFY2027 Q1 · September 10, 2026+10.3% EPS-1.7% move
- CASYFY2027 Q1 · September 8, 2026+8.7% EPS-14.2% move
Get the TJX recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-08-19T17:19:26.720594+00:00
- FN2 earnings calendar · 2026-09-21T01:23:13.071796+00:00
- Polygon adjusted daily market bars · 2026-09-21T13:01:02.480026+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-09-21T13:01:02.476976+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.